MIS Sacroiliac Joint Fusion Market to surpass $ 360 Mn by 2024

September 26, 2019


According to the new research report available at MarketStudyReport.com under the title ‘Global MIS Sacroiliac Market Growth 2019-2024’, the worldwide MIS sacroiliac joint fusion market is expected to exceed US $360 million by the year 2024.
 

Sacroiliac joint (SIJ) fusion is surgical process which merges the pelvis bone to the backbone for stabilization. It is performed for various conditions like infection, spinal instability, cancer, and trauma. Sacroiliac joint fusion may be performed as an open surgical process or as a minimally invasive surgical (MIS) process, though the earlier procedure requires longer recovery time due to larger incision.
 

SIJ fusion, coupled with metal implant devices and bone grafts, is an invasive process which is usually considered as the last resort when all other methods fail to provide a result. However, most SIJ fusion procedures apply MIS approach, wherein instrumentations are placed percutaneously, hence, propelling the growth of MIS sacroiliac joint fusion market.
 

According to the report, MIS sacroiliac join fusion market was worth US $150 million in 2019 and is projected to register a growth of 15.5% CAGR by the year 2024. The study also presents comprehensive insight about the market share, overview, growth opportunities, challenges, and trends impacting the industry growth.
 

The global MIS sacroiliac joint fusion market is analyzed on the basis of product type, application spectrum and regional landscape. Speaking of the product type, the market is segmented as open surgery of sacroiliac joint fusion and minimally invasive surgery. While considering the application spectrum, the market is fragmented as ambulatory surgery centers and hospitals.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1670164/
 

Based on the regional landscape, the market is divided into four major regions which are Europe, Middle East & Africa, Americas, and Asia Pacific. Moreover, North America dominated the MIS SIJ fusion market with 65% share, followed by Europe with 20% share in 2017.
 

The prominent vendors/manufacturers operating In MIS sacroiliac joint fusion market include SIGNUS Medizintechnik, SI-BONE, VGI Medical, Zimmer Biomet, CoreLink, Orthofix, Life Spine, Globus Medical, Xtant Medical, and Zyga Technology.